Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Celgene 4Q09 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Celgene 4Q09

Record revenues for Celgene in 2009

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celgene 4Q09

4Q Revenues: $761 million (+21%)

4Q Earnings: $254 million (loss of $154 million in 4Q08)

FY Revenues: $2.7 billion (+19%)

FY Earnings: $776 million (loss of $1.5 billion in FY08)

Comments: Revlimid sales were up 29% to $1.7 billion in FY09, and up 35% to $497 million in 4Q09. Losses in FY08 were largely attributed to the acquisition of Pharmion Corp. in-process R&D write-downs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters